Empower Clinics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPWCF research report →
Price Chart
About the company
Empower Clinics Inc. functions as a comprehensive healthcare provider, delivering integrated wellness services that address both physical and mental well-being. Patients receive care through various channels, including digital platforms, telemedicine consultations, and advanced medical diagnostics laboratories, catering to populations across the United States and Canada.
- CEO
- Steven J. McAuley
- IPO
- 1997
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on EPWCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.54M
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.54
- P/B
- -0.00
- EV/EBITDA
- -6.72
- Div Yield
- 0.00%
- Gross Margin
- 42.21%
- Op Margin
- -106.26%
- Net Margin
- -0.06%
- ROE
- 0.04%
- ROIC
- 403.20%
Latest fiscal year · YoY change
- Revenue
- $4.66M+6.7%
- Gross Profit
- $1.97M+45.9%
- Op Income
- $-4,954,000
- Net Income
- $-2,826+100.0%
- EPS
- $-0.04+91.8%
- OCF Growth
- +99.9%
- FCF Growth
- +99.9%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.06
- RSI (14)
- 53
- Avg Volume
- 457
No earnings-call transcripts are available for EPWCF yet.
- Free Float
- 0.3%
- Shares Outstanding
- 25.36B
- Float Shares
- 76.93M
Buy/sell ratio 2.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 21, 06 | CAMPBELL JOHN KENNETH | buy | 13,000 |
| Sep 20, 06 | CAMPBELL JOHN KENNETH | buy | 500 |
| Sep 11, 06 | CAMPBELL JOHN KENNETH | buy | 6,500 |
| Sep 7, 06 | Hart Michael Barry | other | 1,000 |
| Sep 7, 06 | Hart Michael Barry | other | 1,000 |
| Sep 7, 06 | CAMPBELL JOHN KENNETH | other | 5,000 |
| Sep 7, 06 | CAMPBELL JOHN KENNETH | other | 5,000 |
| Sep 7, 06 | BROWN DAN | other | 2,000 |
| Sep 7, 06 | BROWN DAN | other | 2,000 |
| Sep 1, 06 | CAMPBELL JOHN KENNETH | buy | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EPWCF coverage
Recent articles, reports, and earnings notes.
No research on EPWCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EPWCF report →Empower Clinics Provides Corporate Update
accesswire.com · Aug 18
Empower Clinics Announces Closing of Second Tranche Private Placement Financing
accesswire.com · Aug 15
Empower Clinics Announces Closing of First Tranche Private Placement Financing
accesswire.com · Aug 9
Empower Clinics Announces Proposal For Division Spin Out
accesswire.com · Aug 1
Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
accesswire.com · Jul 31
Empower Clinics signs letter of intent for equity capital facility
proactiveinvestors.com · Jun 6
Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value
proactiveinvestors.com · May 9
Empower Clinics signs fourth principal investigator for Dallas site
proactiveinvestors.com · May 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.